Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered question first ministerially corrected answering member label previous answer version answering member printed answering member label
tabling member	label

Search

1651487

registered interest
date	10/07/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pharmacy: Standards
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what assessment they have made of the level of support available under the Pharmacy Access Scheme; and whether the criteria includes the (1) quality, (2) opening hours, and (3) range of provision, of existing pharmacies.
tabling member printed	Baroness Bennett of Manor Castle
uin	HL9200
answer	answer is ministerial correction date of answer 19/07/2023 answer text <p><del class="ministerial">The early access to medicines scheme (EAMS) aims to give patients with life threatening or seriously debilitating conditions access to medicines that do not yet have a marketing authorisation when there is a clear unmet medical need.</del></p><p><del class="ministerial">Under the scheme, the Medicines and Healthcare products Regulatory Agency (MHRA) will give a scientific opinion on the benefit/risk balance of the medicine, based on the data available when the EAMS submission was made and the EAMS criteria. The MHRA will make an evaluation of products, including drugs such as for brain tumour treatments, once an application is received.</del></p><p><del class="ministerial">If we do receive an application, it is only made public where an EAMS Scientific Opinion (SO) is awarded. All EAMS SOs are published on the EAMS webpage. All drugs that have previously held an EAMS SO are also published on the EAMS webpage.</del></p><p><ins class="ministerial">The Pharmacy Access Scheme provides additional funding to pharmacies where the next nearest pharmacy is more than a 20-minute walk away. This is calculated as a 0.8-mile walking distance in areas of high deprivation and 1 mile in other areas. In 2021, we agreed updated eligibility criteria and an updated payment model with Community Pharmacy England. To be eligible for the payment, pharmacies must deliver the Community Pharmacist Consultation Service. Quality and opening hours are not included in the eligibility criteria.</ins></p><p> </p><p> </p> answering member printed Lord Markham question first answered 19/07/2023 15:05:50 question first ministerially corrected 20/07/2023 15:18:01 answering member 4948 label Biography information for Lord Markham previous answer version 88780 answering member printed Lord Markham answering member 4948 label Biography information for Lord Markham
tabling member	4719 label Biography information for Baroness Bennett of Manor Castle

1606159

registered interest
date	21/03/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pharmacy: Standards
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what assessment they have made of the impact of (1) reduced pharmacy opening hours, (2) over-capacity pharmacy services, and (3) pharmacists’ staff shortages, on (a) GP, and (b) A&E, services.
tabling member printed	Baroness Wheeler
uin	HL6718
answer	answer is ministerial correction date of answer 30/03/2023 answer text <p>No specific assessment has been made. However, the Department closely monitors the market. In England, access to National Health Service pharmaceutical services remains good with a similar number of community pharmacies as a decade ago and 80% of the population living within 20 minutes walking distance of a community pharmacy.</p><p> </p><p>The Pharmacy Access Scheme supports patient access and provision in areas where there are fewer community pharmacies by providing additional funding to those pharmacies. The Community Pharmacy Contractual Framework 2019-24 five-year deal committed £2.592 billion per year to the sector and outlined a joint vision for how community pharmacy would become more integrated into the NHS, deliver more clinical services, and become the first port of call for minor illnesses<strong>. </strong>The Government continues to implement this deal and has invested a further £100 million across 2022/23 and 2023/24 to support community pharmacies.</p> answering member printed Lord Markham grouped question UIN HL6719 HL6720 question first answered 30/03/2023 10:37:11 answering member 4948 label Biography information for Lord Markham
tabling member	4157 label Biography information for Baroness Wheeler

1606160

registered interest
date	21/03/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pharmacy: Standards
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what steps they are taking (1) to build and expand essential community pharmacy services, and (2) to prevent further closures of both large and small high street pharmacies.
tabling member printed	Baroness Wheeler
uin	HL6719
answer	answer is ministerial correction date of answer 30/03/2023 answer text <p>No specific assessment has been made. However, the Department closely monitors the market. In England, access to National Health Service pharmaceutical services remains good with a similar number of community pharmacies as a decade ago and 80% of the population living within 20 minutes walking distance of a community pharmacy.</p><p> </p><p>The Pharmacy Access Scheme supports patient access and provision in areas where there are fewer community pharmacies by providing additional funding to those pharmacies. The Community Pharmacy Contractual Framework 2019-24 five-year deal committed £2.592 billion per year to the sector and outlined a joint vision for how community pharmacy would become more integrated into the NHS, deliver more clinical services, and become the first port of call for minor illnesses<strong>. </strong>The Government continues to implement this deal and has invested a further £100 million across 2022/23 and 2023/24 to support community pharmacies.</p> answering member printed Lord Markham grouped question UIN HL6718 HL6720 question first answered 30/03/2023 10:37:11 answering member 4948 label Biography information for Lord Markham
tabling member	4157 label Biography information for Baroness Wheeler

1606162

registered interest
date	21/03/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pharmacy: Standards
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what steps they are taking to ensure that there is an adequate supply of essential services provided by pharmacies, particularly the assembly of blister medication packs to support the safe administration of medicines at home by patients, care workers and unpaid carers.
tabling member printed	Baroness Wheeler
uin	HL6721
answer	answer is ministerial correction date of answer 30/03/2023 answer text <p>Compliance support services, for example the dispensing of medicines in blister medication packs, are not nationally commissioned and therefore no data is available on how many compliance aids are assembled every year in England. Under the Equality Act 2010, pharmacies must make reasonable adjustments to their services to help patients covered by the Act which could include compliance aids where appropriate.</p> answering member printed Lord Markham grouped question UIN HL6722 question first answered 30/03/2023 10:36:05 answering member 4948 label Biography information for Lord Markham
tabling member	4157 label Biography information for Baroness Wheeler

1541670

registered interest
date	11/11/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pharmacy: Standards
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what the level of (a) production and (b) capacity is of aseptic services in England.
tabling member constituency	Rother Valley
tabling member printed	Alexander Stafford
uin	85061
answer	answer is ministerial correction date of answer 21/11/2022 answer text <p>The production of aseptically compounded medicines for the National Health Service in England is approximately equal between NHS and commercial suppliers. In 2019/20, approximately 4.5 million doses of compounded medicines were prepared in NHS facilities in England. However, information on the total capacity is not held centrally.</p> answering member constituency Colchester answering member printed Will Quince question first answered 21/11/2022 16:24:10 answering member 4423 label Biography information for Will Quince
tabling member	4866 label Biography information for Alexander Stafford

1491184

registered interest
date	20/07/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pharmacy: Standards
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to reduce dispensing errors in community pharmacies.
tabling member constituency	Enfield North
tabling member printed	Feryal Clark
uin	40981
answer	answer is ministerial correction date of answer 05/09/2022 answer text <p>The Pharmacy (Preparation and Dispensing Errors – Registered Pharmacies) Order 2018 was amended to enable pharmacists to access defences against prosecution following an inadvertent dispensing error. The defences were drafted to incentivise the reporting of errors to enable learning. A survey by the Community Pharmacy Patients Safety Group found that following the amendment, 95% of pharmacists stated that errors were now reported to improve practice.</p><p>In 2022, these defences will be extended to pharmacists working outside a registered premises. It is expected that this will lead to further reporting of dispensing errors and provide greater learning opportunities which will increase patient and consumer safety in registered premises and other pharmacy services.</p><p> </p> answering member constituency Halesowen and Rowley Regis answering member printed James Morris question first answered 05/09/2022 11:54:41 answering member 3992 label Biography information for James Morris
tabling member	4822 label Biography information for Feryal Clark

1303564

registered interest
date	17/03/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pharmacy: Standards
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of whether the performance of community pharmacy during the covid-19 outbreak necessitates the creation of a new national pharmacy contract.
tabling member constituency	York Outer
tabling member printed	Julian Sturdy
uin	170630
answer	answer is ministerial correction date of answer 23/03/2021 answer text <p>Discussions are ongoing with the Pharmaceutical Services Negotiating Committee (PSNC) about additional funding for costs incurred during the COVID-19 pandemic. As part of its assessment of COVID-19 costs incurred by the sector the Government will take account of the £370 million increased advance payments paid to community pharmacies</p><p><br> The support package for community pharmacy also included general COVID-19 business financial support, funding for Bank Holiday openings, social distancing measures and the medicine delivery service to shielded patients and free personal protective equipment, as well as non-monetary support, including the removal of some administrative tasks, flexibility in opening hours and the delayed introduction of new services. The Community Pharmacy Contractual Framework 2019-24 five-year deal was agreed with the PSNC in 2019. Negotiations on year three 2021/22 with the PSNC will begin shortly, which will take account of the effect of the COVID-19 pandemic on community pharmacy.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill grouped question UIN 170629 170631 question first answered 23/03/2021 12:40:44 answering member 4380 label Biography information for Jo Churchill
tabling member	4079 label Biography information for Julian Sturdy